NetworkNewsBreaks – Pressure BioSciences Inc. (P
Post# of 1354
(Total Views: 215)
Posted On: 06/29/2022 4:53:53 PM
NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters ‘Pivotal’ Agreement for Nanoemulsified CBD Spray for Oral Use
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and specialty testing services to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmetics, agrochem and food/beverage industries, is partnering with Safer Medical of Montana (“SMM”) in an exclusive distribution agreement. SMM is a seasoned distributor of wellness products with a focus on veterans. The new partnership entails an agreement for production, distribution, commercial roll-out and finances for a novel, effectively water-soluble, nanoemulsified CBD spray for oral use. According to the announcement, SMM’s roll-out and distribution plan anticipates revenues of $3 million or more over the first 12-months post-release of the product, with PBI receiving more than $1 million in revenues. This will be the first commercial product that utilizes Pressure BioSciences’ patented Ultra Shear Technology(TM) platform. “This first UST commercialization and partnering agreement with Captain Ackerson and Safer Medical of Montana is a pivotal transition moment in the history of PBI,” said Pressure BioSciences president and CEO Richard T. Schumacher in the press release. “We are expecting to announce significant additional agreements in the very near future, specifically in markets with an expected quick ramp to revenue, such as cosmetics, agrochem and nutraceuticals. We also believe that our co-leadership role in the Food Industry Consortium with partner The Ohio State University, whose mission is to introduce the UST platform to food and beverage companies worldwide, will soon result in additional revenue-generating agreements. We expect that the substantial revenue expected from these future agreements will accelerate balance sheet improvements and help finance PBI’s operations, investments, growth and trajectory to profitability before the end of 2023.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and specialty testing services to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmetics, agrochem and food/beverage industries, is partnering with Safer Medical of Montana (“SMM”) in an exclusive distribution agreement. SMM is a seasoned distributor of wellness products with a focus on veterans. The new partnership entails an agreement for production, distribution, commercial roll-out and finances for a novel, effectively water-soluble, nanoemulsified CBD spray for oral use. According to the announcement, SMM’s roll-out and distribution plan anticipates revenues of $3 million or more over the first 12-months post-release of the product, with PBI receiving more than $1 million in revenues. This will be the first commercial product that utilizes Pressure BioSciences’ patented Ultra Shear Technology(TM) platform. “This first UST commercialization and partnering agreement with Captain Ackerson and Safer Medical of Montana is a pivotal transition moment in the history of PBI,” said Pressure BioSciences president and CEO Richard T. Schumacher in the press release. “We are expecting to announce significant additional agreements in the very near future, specifically in markets with an expected quick ramp to revenue, such as cosmetics, agrochem and nutraceuticals. We also believe that our co-leadership role in the Food Industry Consortium with partner The Ohio State University, whose mission is to introduce the UST platform to food and beverage companies worldwide, will soon result in additional revenue-generating agreements. We expect that the substantial revenue expected from these future agreements will accelerate balance sheet improvements and help finance PBI’s operations, investments, growth and trajectory to profitability before the end of 2023.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Pressure Biosciences (PBIO) Stock Research Links
Scroll down for more posts ▼